accountJeffrey Kindler recently gave an indication of the scale of the FDA’s problem in inspecting Chinese pharmaceutical plants. After recent scandals involving tainted baby formula and heparin made in Chinese factories, the FDA in late November beefed up...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Expands in China Faster Than the FDA
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account